Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
| الحاوية / القاعدة: | Pediatric Neurology Briefs |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.pediatricneurologybriefs.com/articles/632 |